Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

KRX-0401 Perifosine

In August 2009 Keryx began Phase III trials of KRX-0401 in combination with other drugs, with the primary endpoint of survival without progression.

Go Top